1-3 of 3
Teruhiro Utsugi, PhD
Close
Sort by
Journal Articles

TAS4464, a Novel, Highly Potent NEDD8-Activating Enzyme Inhibitor Shows Antitumor Activity in Ibrutinib-Insensitive Mantle Cell Lymphoma Via Inactivation of the NF-κB Pathway

Hiromi Muraoka, MS, Chihoko Yoshimura, PhD, Shingo Tsuji, MS, Akihiro Hashimoto, Fumio Nakagawa, Takashi Mizutani, PhD, Shuichi Ohkubo, PhD, Kenichi Matsuo, PhD, Teruhiro Utsugi, PhD, Yoshikazu Iwasawa, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4103.
https://doi.org/10.1182/blood.V130.Suppl_1.4103.4103
Published: 2017
Journal Articles

Antitumor Activities Of An Oral Selective HSP90α/β Inhibitor, TAS-116, In Combination With Bortezomib In Multiple Myeloma

Rikio Suzuki, MD, PhD, Teru Hideshima, MD, PhD, Shuichi Ohkubo, PhD, Naoya Mimura, MD, PhD, Jiro Minami, MD, PhD, Hiroto Ohguchi, MD, PhD, Shohei Kikuchi, MD, PhD, Diana D. Cirstea, Francesca Cottini, MD, Dharminder Chauhan, PhD, Paul G. Richardson, MD, Nikhil C. Munshi, MD, Teruhiro Utsugi, PhD, Kenneth C. Anderson, MD
Journal: Blood
Blood (2013) 122 (21): 4429.
https://doi.org/10.1182/blood.V122.21.4429.4429
Published: 2013
Journal Articles

TAS-117, a Novel Selective Akt Inhibitor Demonstrates Significant Growth Inhibition in Multiple Myeloma Cells in Vitro and in Vivo

Naoya Mimura, Hiroto Ohguchi, Diana Cirstea, MD, Francesca Cottini, Gullu Topal Gorgun, PhD, Jiro Minami, Rikio Suzuki, Toshiyasu Shimomura, PhD, Teruhiro Utsugi, PhD, Teru Hideshima, MD, PhD, Kenneth C. Anderson, MD
Journal: Blood
Blood (2012) 120 (21): 942.
https://doi.org/10.1182/blood.V120.21.942.942
Published: 2012